Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 32% ± 18% | |
GABAergic neuron | 4 studies | 30% ± 10% | |
interneuron | 3 studies | 30% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 29% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 4601.19 | 2542 / 2642 | 98% | 16.58 | 693 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 36.64 | 80 / 80 |
skin | 1% | 2.00 | 14 / 1809 | 86% | 17.06 | 404 / 472 |
lung | 34% | 104.99 | 196 / 578 | 22% | 0.91 | 256 / 1155 |
uterus | 20% | 51.92 | 34 / 170 | 34% | 1.36 | 156 / 459 |
adrenal gland | 3% | 10.04 | 8 / 258 | 39% | 2.10 | 89 / 230 |
ovary | 4% | 7.23 | 7 / 180 | 37% | 2.57 | 158 / 430 |
breast | 7% | 16.88 | 34 / 459 | 29% | 1.64 | 328 / 1118 |
prostate | 1% | 1.55 | 2 / 245 | 28% | 0.71 | 143 / 502 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.77 | 12 / 45 |
thymus | 17% | 42.28 | 108 / 653 | 8% | 0.23 | 49 / 605 |
esophagus | 4% | 9.56 | 55 / 1445 | 20% | 0.66 | 36 / 183 |
kidney | 15% | 32.69 | 13 / 89 | 7% | 0.21 | 60 / 901 |
pancreas | 0% | 0 | 0 / 328 | 21% | 0.87 | 37 / 178 |
spleen | 15% | 35.67 | 36 / 241 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 12% | 0.38 | 59 / 504 |
stomach | 2% | 4.13 | 7 / 359 | 8% | 0.30 | 23 / 286 |
intestine | 4% | 8.49 | 35 / 966 | 6% | 0.25 | 29 / 527 |
adipose | 6% | 17.47 | 78 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 6.14 | 31 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 2% | 0.17 | 8 / 406 |
heart | 0% | 0.61 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0018242 | Biological process | protein O-linked glycosylation via serine |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030145 | Molecular function | manganese ion binding |
GO_0030144 | Molecular function | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MGAT5B |
Protein name | Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.-) (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase B) (GlcNAc-T Vb) (GNT-Vb) (hGnTVb) (Mannoside acetylglucosaminyltransferase 5B) (N-acetylglucosaminyl-transferase Vb) (N-acetylglucosaminyltransferase IX) (GNT-IX) Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase (EC 2.4.1.155) |
Synonyms | KIAA2008 |
Description | FUNCTION: Glycosyltransferase that acts on alpha-linked mannose of N-glycans and O-mannosyl glycans. Catalyzes the transfer of N-acetylglucosamine (GlcNAc) to the beta 1-6 linkage of the mannose residue of GlcNAc-beta1,2-Man-alpha on both the alpha1,3- and alpha1,6-linked mannose arms in the core structure of N-glycan. Also acts on the GlcNAc-beta1,2-Man-alpha1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan. Plays an active role in modulating integrin and laminin-dependent adhesion and migration of neuronal cells via its activity in the O-mannosyl glycan pathway. . |
Accessions | Q3V5L5 ENST00000565675.1 H3BR20 ENST00000428789.6 [Q3V5L5-2] H3BQ65 ENST00000301618.8 [Q3V5L5-5] ENST00000565043.5 ENST00000569840.7 [Q3V5L5-1] |